MRK: Merck & Co., Inc. Stock

by  •  • Comments Off on MRK: Merck & Co., Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 318,753.67
Enterprise Value ($M) 348,753.67
Book Value ($M) 37,635.00
Book Value / Share 14.86
Price / Book 8.47
NCAV ($M) -33,980.00
NCAV / Share -13.42
Price / NCAV -9.38

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.02
Return on Equity (ROE) 0.05

Liquidity (mrq)
Quick Ratio 0.99
Current Ratio 1.25

Balance Sheet (mrq) ($M)
Current Assets 31,445.00
Assets 105,849.00
Liabilities 65,425.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 60,115.00
Operating Income 17,611.00
Net Income 365.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 13,006.00
Cash from Investing -14,083.00
Cash from Financing -4,810.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 9.66 7.73
01-26 13G/A BlackRock Inc. 8.00 -6.13

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 752,768 4,746,667 15.86
2024-07-25 541,845 6,030,464 8.99
2024-07-24 384,544 4,327,562 8.89
2024-07-23 347,605 3,245,863 10.71
2024-07-22 315,227 2,910,958 10.83

(click for more detail)

Similar Companies
HYAC – Haymaker Acquisition Corp. 4 JNJ – Johnson & Johnson
LLY – Eli Lilly and Company NUVB – Nuvation Bio Inc.
OGN – Organon & Co.


Financial data and stock pages provided by
Fintel.io

Finpedia: Merck & Co